These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 12571859

  • 41. A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus disease.
    Lake RA, Staines NA.
    Clin Exp Immunol; 1988 Jul; 73(1):103-10. PubMed ID: 3048810
    [Abstract] [Full Text] [Related]

  • 42. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS.
    J Immunol; 2000 Jan 15; 164(2):786-94. PubMed ID: 10623824
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H, Yoshida M, Izui S, Lambert PH.
    J Clin Invest; 1985 Aug 15; 76(2):685-94. PubMed ID: 3875630
    [Abstract] [Full Text] [Related]

  • 47. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.
    Anam K, Amare M, Naik S, Szabo KA, Davis TA.
    Lupus; 2009 Apr 15; 18(4):318-31. PubMed ID: 19276300
    [Abstract] [Full Text] [Related]

  • 48. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE.
    J Autoimmun; 1997 Aug 15; 10(4):367-73. PubMed ID: 9237800
    [Abstract] [Full Text] [Related]

  • 49. Effect of combining ACE inhibitor and statin in lupus-prone mice.
    Shimazu H, Kinoshita K, Hino S, Yano T, Kishimoto K, Nagare Y, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M.
    Clin Immunol; 2010 Aug 15; 136(2):188-96. PubMed ID: 20403731
    [Abstract] [Full Text] [Related]

  • 50. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.
    J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185
    [Abstract] [Full Text] [Related]

  • 51. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K, Qu WM, Zhang MC, Fujii H, Furukawa H, Miyazaki T, Iwano M, Saito Y, Nose M, Ono M.
    Scand J Immunol; 2007 Dec 15; 66(6):654-61. PubMed ID: 17983422
    [Abstract] [Full Text] [Related]

  • 52. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice.
    Zhao JH, Sun SJ, Horiguchi H, Arao Y, Kanamori N, Kikuchi A, Oguma E, Kayama F.
    Int Immunopharmacol; 2005 Oct 15; 5(11):1601-10. PubMed ID: 16039550
    [Abstract] [Full Text] [Related]

  • 53. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 54. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.
    Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS.
    Eur J Immunol; 2006 May 15; 36(5):1296-308. PubMed ID: 16541466
    [Abstract] [Full Text] [Related]

  • 55. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 15; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 56. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y, Koarada S, Tomiyoshi Y, Morito F, Mitamura M, Haruta Y, Ohta A, Nagasawa K.
    Clin Immunol; 2006 Aug 15; 120(2):179-88. PubMed ID: 16616645
    [Abstract] [Full Text] [Related]

  • 57. Genetic basis of tissue specificity of vasculitis in MRL/lpr mice.
    Yamada A, Miyazaki T, Lu LM, Ono M, Ito MR, Terada M, Mori S, Hata K, Nozaki Y, Nakatsuru S, Nakamura Y, Onji M, Nose M.
    Arthritis Rheum; 2003 May 15; 48(5):1445-51. PubMed ID: 12746919
    [Abstract] [Full Text] [Related]

  • 58. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
    Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M.
    Rheumatology (Oxford); 2004 Sep 15; 43(9):1121-8. PubMed ID: 15213333
    [Abstract] [Full Text] [Related]

  • 59. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice.
    Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH.
    J Immunol; 1987 Jun 01; 138(11):3785-92. PubMed ID: 3495570
    [Abstract] [Full Text] [Related]

  • 60. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M, Kariyone A, Shiraki M.
    Clin Exp Immunol; 1985 Jan 01; 59(1):161-8. PubMed ID: 3918816
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.